Fintel reports that on February 20, 2025, B. Riley Securities initiated coverage of Electromed (NYSEAM:ELMD) with a Buy ...

B. Riley launched its coverage of Electromed (OTCQB:EMED) with a Buy recommendation and a $38 per share target, arguing that the company, being the final remaining pure-play stock in a market for a ...

B. Riley analyst Kyle Bauser initiated coverage of Electromed (ELMD) with a Buy rating and $38 price target Electromed is a profitable, ...

StockNews.com lowered shares of Electromed (NYSE:ELMD – Free Report) from a strong-buy rating to a buy rating in a report issued on Wednesday morning. Electromed Stock Performance NYSE ELMD opened at ...

Facing a Shift in Market Trends?

NEW PRAGUE, Minn., February 11, 2025--Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial ...

Lake Street analyst Brooks O’Neil raised the firm’s price target on Electromed (ELMD) to $36 from $33 and keeps a Buy rating on the shares, ...

Electromed, Inc. (NYSEMKT:ELMD) engages in the manufacturing of airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care.

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will release its ...

Electromed continues to focus on its core Homecare segment, which achieved 15.2% year-over-year revenue growth to $14.6M. The average annualized revenue per direct sales representative stood at $ ...

Kathleen Skarvan, a director at Electromed, Inc. (NYSE:ELMD), recently reported significant stock transactions involving the company's common stock. The transactions come as the stock has shown ...

Good afternoon, and welcome to the Electromed Second Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being ...